We do not think that the size of the study population was miscalculated, as previous studies in the field have shown clearly a higher prevalence of both CAH and CYP21A2-variation carriership despite significantly smaller study populations compared with ours (26). Here, CYP21A2 is linked to congenital adrenal hyperplasia.